Your browser doesn't support javascript.
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.
Isaikina, Polina; Tsai, Ching-Ju; Dietz, Nikolaus; Pamula, Filip; Grahl, Anne; Goldie, Kenneth N; Guixà-González, Ramon; Branco, Camila; Paolini-Bertrand, Marianne; Calo, Nicolas; Cerini, Fabrice; Schertler, Gebhard F X; Hartley, Oliver; Stahlberg, Henning; Maier, Timm; Deupi, Xavier; Grzesiek, Stephan.
  • Isaikina P; Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
  • Tsai CJ; Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland.
  • Dietz N; Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
  • Pamula F; Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland.
  • Grahl A; Department of Biology, ETH Zurich, CH-8093 Zurich, Switzerland.
  • Goldie KN; Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
  • Guixà-González R; Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, CH-4058 Basel, Switzerland.
  • Branco C; Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland.
  • Paolini-Bertrand M; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Calo N; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Cerini F; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Schertler GFX; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Hartley O; Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland. stephan.grzesiek@unibas.ch xavier.deupi@psi.ch oliver.hartley@unige.ch gebhard.schertler@psi.ch.
  • Stahlberg H; Department of Biology, ETH Zurich, CH-8093 Zurich, Switzerland.
  • Maier T; Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. stephan.grzesiek@unibas.ch xavier.deupi@psi.ch oliver.hartley@unige.ch gebhard.schertler@psi.ch.
  • Deupi X; Orion Biotechnology, Ottawa, Canada.
  • Grzesiek S; Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, CH-4058 Basel, Switzerland.
Sci Adv ; 7(25)2021 06.
Article in English | MEDLINE | ID: covidwho-1276874
ABSTRACT
The human CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor (GPCR) that plays a major role in inflammation and is involved in cancer, HIV, and COVID-19. Despite its importance as a drug target, the molecular activation mechanism of CCR5, i.e., how chemokine agonists transduce the activation signal through the receptor, is yet unknown. Here, we report the cryo-EM structure of wild-type CCR5 in an active conformation bound to the chemokine super-agonist [6P4]CCL5 and the heterotrimeric Gi protein. The structure provides the rationale for the sequence-activity relation of agonist and antagonist chemokines. The N terminus of agonist chemokines pushes onto specific structural motifs at the bottom of the orthosteric pocket that activate the canonical GPCR microswitch network. This activation mechanism differs substantially from other CC chemokine receptors that bind chemokines with shorter N termini in a shallow binding mode involving unique sequence signatures and a specialized activation mechanism.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, CCR5 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Sciadv.abg8685

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, CCR5 Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Sciadv.abg8685